Zymeworks (ZYME) Misses Q4 EPS by 31c

Zymeworks (NASDAQ: ZYME) reported Q4 EPS of ($0.31). Revenue for the quarter came in at $31.03 million.

For earnings history and earnings-related data on Zymeworks (ZYME) click here.

You May Also Be Interested In

• Apple suing OpenAI over alleged misappropriation of trade secrets
• CORVEX (MOVE) files for 53.39M share offering by selling stockholders
• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'